Values | Univariate analysis OR (95% CI) | P | Multivariate analysis OR (95% CI) (Model 1*) | P | Multivariate analysis OR (95% CI) (Model 2†) | P |
---|---|---|---|---|---|---|
Age > 60 | 1.28 (0.64–2.58) | 0.481 |  |  |  |  |
Male | 1.74 (0.66–4.59) | 0.265 |  |  |  |  |
BMI ≤ 23.9 | 0.93 (0.46–1.89) | 0.845 |  |  |  |  |
Poor differentiation | 1.75 (0.75–4.11) | 0.196 |  |  |  |  |
Linitis plastica | NA | NA | Â | Â | Â | Â |
NACT cycles ≥ 4 | 3.54 (1.56–8.05) | 0.002 | 3.09 (1.30–7.33) | 0.011 | 3.20 (1.36–7.55) | 0.008 |
Triplet drug | 4.73 (1.24–18.08) | 0.023 | 3.09 (0.72–13.31) | 0.130 | 3.31 (0.78–13.98) | 0.103 |
CEA ≤ 5.72 | 2.06 (0.32–6.90) | 0.241 |  |  |  |  |
CA19-9 ≤ 15.00 | 1.53 (0.73–3.21) | 0.259 |  |  |  |  |
CA72-4 ≤ 2.60 | 2.29 (1.11–4.72) | 0.025 |  |  | 2.32 (1.11–4.84) | 0.025 |
Post-NACT CTM | Â | Â | Â | Â | Â | Â |
 0 | 4.33 (1.39–13.49) | 0.01 | 4.19 (1.33–13.14) | 0.014 |  |  |
 1 | 2.88 (0.94–8.77) | 0.060 | 2.75 (0.89–8.50) | 0.078 |  |  |
 2/3 | 1.00 |  | 1.00 |  |  |  |